How to Use CA-125 More Effectively in the Diagnosis of Deep Endometriosis

• Published in: BioMed research international 2017-01, Vol.2017 (2017), p.1-6
• Main Authors: Pereira, Thiago Rodrigues Dantas, Soares, Leila Cristina, Raymundo, Thiers Soares, Oliveira, Marco Aurelio Pinho, Evangelista, Alessandra Viviane
• Format: Article
• Language: English
• Subjects: Adult; Biomedical research; CA-125 Antigen - blood; Case-Control Studies; Diagnosis; Endometriosis; Endometriosis - blood; Endometriosis - physiopathology; Female; Gynecology; Humans; Laparoscopy; Menstrual Cycle - blood; Menstruation; NMR; Nuclear magnetic resonance; Patients; Performance evaluation; Prospective Studies; Studies; Surgery; Ultrasonic imaging; Womens health
• ISSN: 2314-6133; 2314-6141
• DOI: 10.1155/2017/9857196

Deep infiltrative endometriosis (DIE) is a severe form of the disease. The median time interval from the onset of symptoms to diagnosis of endometriosis is around 8 years. In this prospective study patients were divided into two groups: cases (34 DIE patients) and control (20 tubal ligation patients). The main objective of this study was to evaluate the performance of CA-125 measurement in the menstrual and midcycle phases of the cycle, as well as the difference in its levels between the two phases, for the early diagnosis of DIE. Area Under the Curve (AUC) of CA-125 in menstrual phase and of the difference between menstrual and midcycle phases had the best performance (both with AUC = 0.96), followed by CA-125 in the midcycle (AUC = 0.89). The ratio between menstrual and midcycle phases had the worst performance. CA-125 may be useful for the diagnosis of deep endometriosis, especially when both are collected during menstruation and in midcycle. These may help to decrease the long interval until the definitive diagnosis of DIE. Multicentric studies with larger samples should be performed to better evaluate the cost-effectiveness of measuring CA-125 in two different phases of the menstrual cycle.